Kumar Ramesh
Insider CIK 1580074 · ONTX President and CEO, Director · OCGN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OCGN Ocugen, Inc. | A Award deriv | 2023-06-09 | 2023-06-09 | 112,205 | — | $0 | 112,205 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise deriv | 2022-10-06 | 2022-10-07 | 4,500 | — | $0 | 4,500 | SEC↗ |
| OCGN Ocugen, Inc. | S Sale | 2022-10-06 | 2022-10-07 | 4,500 | $1.83 | $8.2K | 0 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise | 2022-10-06 | 2022-10-07 | 4,500 | $0.51 | $2.3K | 4,500 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise deriv | 2022-07-18 | 2022-07-20 | 7,500 | — | $0 | 9,000 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise | 2022-07-18 | 2022-07-20 | 7,500 | $0.51 | $3.8K | 7,500 | SEC↗ |
| OCGN Ocugen, Inc. | S Sale | 2022-07-18 | 2022-07-20 | 7,500 | $2.57 | $19.3K | 0 | SEC↗ |
| OCGN Ocugen, Inc. | A Award deriv | 2022-06-07 | 2022-06-08 | 140,091 | — | $0 | 140,091 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise deriv | 2022-04-18 | 2022-04-20 | 7,500 | — | $0 | 16,500 | SEC↗ |
| OCGN Ocugen, Inc. | S Sale | 2022-04-18 | 2022-04-20 | 7,500 | $2.83 | $21.2K | 0 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise | 2022-04-18 | 2022-04-20 | 7,500 | $0.51 | $3.8K | 7,500 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise deriv | 2022-01-18 | 2022-01-20 | 7,500 | — | $0 | 24,000 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise | 2022-01-18 | 2022-01-20 | 7,500 | $0.51 | $3.8K | 7,500 | SEC↗ |
| OCGN Ocugen, Inc. | S Sale | 2022-01-18 | 2022-01-20 | 7,500 | $4.07 | $30.5K | 0 | SEC↗ |
| OCGN Ocugen, Inc. | A Award deriv | 2021-12-16 | 2021-12-17 | 16,335 | — | $0 | 16,335 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise deriv | 2021-10-18 | 2021-10-20 | 7,500 | — | $0 | 31,500 | SEC↗ |
| OCGN Ocugen, Inc. | S Sale | 2021-10-18 | 2021-10-20 | 7,500 | $8.13 | $61.0K | 0 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise | 2021-10-18 | 2021-10-20 | 7,500 | $0.51 | $3.8K | 7,500 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise deriv | 2021-07-19 | 2021-07-21 | 7,500 | — | $0 | 39,000 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise | 2021-07-19 | 2021-07-21 | 7,500 | $0.51 | $3.8K | 7,500 | SEC↗ |
| OCGN Ocugen, Inc. | S Sale | 2021-07-19 | 2021-07-21 | 7,500 | $6.40 | $48.0K | 0 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise deriv | 2021-04-19 | 2021-04-21 | 7,500 | — | $0 | 46,500 | SEC↗ |
| OCGN Ocugen, Inc. | M Exercise | 2021-04-19 | 2021-04-21 | 7,500 | $0.51 | $3.8K | 7,500 | SEC↗ |
| OCGN Ocugen, Inc. | S Sale | 2021-04-19 | 2021-04-21 | 7,500 | $5.33 | $40.0K | 0 | SEC↗ |
| OCGN Ocugen, Inc. | A Award deriv | 2021-01-01 | 2021-01-04 | 126,000 | — | $0 | 126,000 | SEC↗ |
| OCGN Ocugen, Inc. | A Award deriv | 2020-01-02 | 2020-01-03 | 54,000 | — | $0 | 54,000 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2018-07-26 | 2018-07-30 | 1,065,600 | — | $0 | 1,065,600 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2018-02-23 | 2018-02-27 | 73,220 | — | $0 | 73,220 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2018-01-03 | 2018-01-05 | 64,885 | — | $0 | 64,885 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | P Buy | 2017-04-26 | 2017-04-28 | 23,810 | $2.10 | $50.0K | 102,227 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2017-01-17 | 2017-01-19 | 44,027 | — | $0 | 44,027 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2016-12-15 | 2016-12-19 | 12,673 | — | $0 | 12,673 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2016-09-01 | 2016-09-01 | 44,000 | — | $0 | 44,000 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | X Exercise deriv | 2016-07-29 | 2016-08-10 | 38,071 | — | $0 | 38,071 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | X Exercise | 2016-07-29 | 2016-08-10 | 50,765 | $4.10 | $208.1K | 78,417 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | X Exercise deriv | 2016-07-26 | 2016-08-10 | 41,475 | — | $0 | 0 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2016-01-26 | 2016-01-28 | 146,440 | — | $0 | 146,440 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2015-09-25 | 2015-10-01 | 87,500 | — | $0 | 87,500 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2015-04-16 | 2015-04-20 | 87,500 | — | $0 | 87,500 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2014-12-18 | 2014-12-22 | 175,000 | — | $0 | 175,000 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | M Exercise deriv | 2014-02-10 | 2014-02-11 | 20,000 | — | $0 | 16,739 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | S Sale | 2014-02-10 | 2014-02-11 | 20,000 | $15.11 | $302.2K | 276,500 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | M Exercise | 2014-02-10 | 2014-02-11 | 20,000 | $6.00 | $120.0K | 296,500 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | M Exercise deriv | 2014-02-07 | 2014-02-11 | 13,543 | — | $0 | 36,739 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | M Exercise | 2014-02-07 | 2014-02-11 | 13,543 | $6.00 | $81.3K | 290,043 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | M Exercise deriv | 2014-02-03 | 2014-02-03 | 20,000 | — | $0 | 50,282 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | S Sale | 2014-02-03 | 2014-02-03 | 20,000 | $15.07 | $301.4K | 276,500 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | M Exercise | 2014-02-03 | 2014-02-03 | 20,000 | $6.00 | $120.0K | 296,500 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | M Exercise deriv | 2014-01-31 | 2014-02-03 | 20,000 | — | $0 | 70,282 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | S Sale | 2014-01-31 | 2014-02-03 | 20,000 | $15.03 | $300.6K | 276,500 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | M Exercise | 2014-01-31 | 2014-02-03 | 20,000 | $6.00 | $120.0K | 296,500 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | M Exercise deriv | 2014-01-30 | 2014-02-03 | 5,256 | — | $0 | 0 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | M Exercise deriv | 2014-01-30 | 2014-02-03 | 14,744 | — | $0 | 90,282 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | S Sale | 2014-01-30 | 2014-02-03 | 20,000 | $15.05 | $301.0K | 276,500 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | M Exercise | 2014-01-30 | 2014-02-03 | 14,744 | $6.00 | $88.5K | 296,500 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | M Exercise | 2014-01-30 | 2014-02-03 | 5,256 | $2.67 | $14.0K | 281,756 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 135,000 | — | $0 | 135,000 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | P Buy | 2013-11-15 | 2013-11-18 | 1,100 | $12.02 | $13.2K | 276,500 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion deriv | 2013-07-30 | 2013-08-01 | 500 | — | $0 | 0 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion deriv | 2013-07-30 | 2013-08-01 | 4,667 | — | $0 | 0 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion deriv | 2013-07-30 | 2013-08-01 | 100 | — | $0 | 0 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion deriv | 2013-07-30 | 2013-08-01 | 20,645 | — | $0 | 0 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion deriv | 2013-07-30 | 2013-08-01 | 983 | — | $0 | 0 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion deriv | 2013-07-30 | 2013-08-01 | 2,209 | — | $0 | 0 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion deriv | 2013-07-30 | 2013-08-01 | 1,084 | — | $0 | 0 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion deriv | 2013-07-30 | 2013-08-01 | 500 | — | $0 | 0 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion deriv | 2013-07-30 | 2013-08-01 | 765 | — | $0 | 0 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion | 2013-07-30 | 2013-08-01 | 811 | — | $0 | 267,325 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion | 2013-07-30 | 2013-08-01 | 1,657 | — | $0 | 266,514 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion | 2013-07-30 | 2013-08-01 | 17,424 | — | $0 | 264,120 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion | 2013-07-30 | 2013-08-01 | 3,748 | — | $0 | 246,696 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | P Buy | 2013-07-30 | 2013-08-01 | 6,667 | $15.00 | $100.0K | 275,400 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion | 2013-07-30 | 2013-08-01 | 75 | — | $0 | 268,733 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion | 2013-07-30 | 2013-08-01 | 375 | — | $0 | 268,658 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion | 2013-07-30 | 2013-08-01 | 573 | — | $0 | 268,283 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion | 2013-07-30 | 2013-08-01 | 385 | — | $0 | 267,710 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | C Conversion | 2013-07-30 | 2013-08-01 | 737 | — | $0 | 264,857 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2013-07-25 | 2013-07-29 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | A Award deriv | 2013-07-25 | 2013-07-29 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ONTX Onconova Therapeutics, Inc | S Sale | 2013-02-07 | 2014-02-11 | 13,543 | $15.02 | $203.4K | 276,500 | SEC↗ |